Over 20 million podcasts, powered by
1k
900
))
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on April 19, 2025 10:55 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notice, pouring billions into partnerships and research projects across the country. But can China maintain this momentum — or will political pressure and consumer skepticism slow things down?
Skip Montreux and Dez Morgan explore how China’s pharmaceutical and biotech sectors are reshaping the global healthcare landscape. They trace the industry’s evolution from state-run factories to world-class R&D centers, discuss the surge in foreign investment, and introduce key players like Akeso Biopharma. Along the way, they also unpack some of the challenges that may lie ahead for this fast-growing industry.
Their conversation is a great learning resource if you want to build your English listening comprehension skills and expand your business vocabulary. Key points of their discussion include:
Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes.
Visit d2benglish.com/membership for more information.
Follow Down to Business English on Apple podcasts, rate the show, and leave a comment.
Contact Skip, Dez, and Samantha at
Follow Skip & Dez
201 episodes
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on April 19, 2025 10:55 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
China is fast becoming a major player in the global pharmaceutical and biotech industries. Once focused primarily on generic and me-too drugs, Chinese companies are now making headlines with innovative breakthroughs in oncology and gene therapy. Foreign investors are taking notice, pouring billions into partnerships and research projects across the country. But can China maintain this momentum — or will political pressure and consumer skepticism slow things down?
Skip Montreux and Dez Morgan explore how China’s pharmaceutical and biotech sectors are reshaping the global healthcare landscape. They trace the industry’s evolution from state-run factories to world-class R&D centers, discuss the surge in foreign investment, and introduce key players like Akeso Biopharma. Along the way, they also unpack some of the challenges that may lie ahead for this fast-growing industry.
Their conversation is a great learning resource if you want to build your English listening comprehension skills and expand your business vocabulary. Key points of their discussion include:
Become a D2B Member today for to access to our -- NEW!!!-- interactive audio scripts, PDF Audio Script Library, Bonus Vocabulary episodes, and D2B Member-only episodes.
Visit d2benglish.com/membership for more information.
Follow Down to Business English on Apple podcasts, rate the show, and leave a comment.
Contact Skip, Dez, and Samantha at
Follow Skip & Dez
201 episodes
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.
1k900
Share
